Many Monsanto Company(MON) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Monsanto Company was Upgraded by CLSA to Outperform on Jan 6, 2017.
Company has reported several Insider transactions to the SEC, on Jan 27, 2017, Michael K Stern (VP, and CEO, Climate) sold 5,670 shares at 110.00 per share price.On Jan 12, 2017, Steven Mizell (EVP, Chief HR Officer) sold 2,525 shares at 108.56 per share price.On Nov 17, 2016, Kerry J Preete (EVP, Chief Strategy Officer) sold 2,745 shares at 100.96 per share price.
Monsanto Company Last issued its quarterly earnings results on Jan 5, 2017. The company reported $0.21 EPS for the quarter, beating the analyst consensus estimate by $ 0.22. Analyst had a consensus of $-0.01. The company had revenue of $2650.00 million for the quarter, compared to analysts expectations of $2295.33 million. The companys revenue was up 19.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.11 EPS.
Monsanto Company (NYSE:MON) has received a short term rating of buy from experts at Zacks with a rank of 2. The stock has been rated an average of 1.7 by 10 Brokerage Firm. 6 Wall Street Firms have rated the stock as a strong buys. 1 stock experts have also suggested a buy rating. 3 Brokerage Firms have advised hold.
Monsanto Company (NYSE:MON): 10 Analyst have given the stock of Monsanto Company (NYSE:MON) a near short term price target of $118. The standard deviation reading, which is a measure by which the stock price is expected to swing away from the mean estimate, is at $13.57. The higher price target estimate is at $128 while the lower price estimates are fixed at $88.
Monsanto Company (NYSE:MON) witnessed a decline in the market cap on Tuesday as its shares dropped 0.04% or 0.04 points. After the session commenced at $107.5, the stock reached the higher end at $107.86 while it hit a low of $107.44. With the volume soaring to 1,386,373 shares, the last trade was called at $107.63. The company has a 52-week high of $114.26. The company has a market cap of $47,202 million and there are 438,554,830 shares in outstanding. The 52-week low of the share price is $83.73.
Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.